Schrödinger to Present at H.C. Wainwright BioConnect Conference

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will participate in a fireside chat at the H.C. Wainwright BioConnect Conference, with a pre-recorded presentation set for January 10, 2022, at 11:00 a.m. ET. The webcast will be available on-demand on Schrödinger’s website under "News & Events" and archived for seven days. The company is known for its physics-based software platform that accelerates the discovery of therapeutics and materials. Founded in 1990, Schrödinger employs over 500 staff and collaborates globally.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the H.C. Wainwright BioConnect Conference. The pre-recorded presentation will be available on Monday, January 10, 2022, at 11:00 a.m. ET.

The “on demand” webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar and will be archived for approximately seven days.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 500 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Twitter, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220105005453/en/

Jaren Irene Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Tracy Lessor

Schrödinger, Inc.

tracy.lessor@schrodinger.com

617-519-9827

Source: Schrödinger, Inc.

FAQ

What is the date and time of Schrödinger's presentation at the H.C. Wainwright BioConnect Conference?

Schrödinger's presentation is scheduled for January 10, 2022, at 11:00 a.m. ET.

Where can I access the on-demand webcast of Schrödinger's conference presentation?

The on-demand webcast can be accessed on Schrödinger’s website under the 'News & Events' section.

How long will the broadcast of Schrödinger's conference presentation be available?

The webcast will be archived and available for approximately seven days.

What technology does Schrödinger use for drug discovery?

Schrödinger utilizes a physics-based software platform to accelerate the discovery of therapeutics and materials.

How many employees does Schrödinger have?

Schrödinger has over 500 employees.

In how many countries does Schrödinger operate?

Schrödinger collaborates with customers and partners in more than 70 countries.